riluzole and lithium
riluzole has been researched along with lithium in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Charney, DS; De Jesus, G; Denicoff, KD; Luckenbaugh, DA; Manji, HK; Quiroz, JA; Singh, JB; Zarate, CA | 1 |
| Ayala, V; Brunet, N; Calderó, J; Esquerda, JE; Hereu, M; Piedrafita, L; Tarabal, O | 1 |
| Aggarwal, SP; Conwit, RA; Cudkowicz, M; Jackson, KE; Kaufman, P; McKinley, J; Pinto, H; Schoenfeld, D; Shefner, J; Simpson, E; Zinman, L | 1 |
| Arranz-Tagarro, JA; Galán, L; García, AG; Gómez-Pinedo, U; Guerrero, A; Martínez-Vila, E; Matías-Guiu, J; Vela, A; Viña, D; Yáñez, M | 1 |
Trials
2 trial(s) available for riluzole and lithium
| Article | Year |
|---|---|
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Humans; Lithium; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Riluzole; Time Factors; Treatment Outcome | 2005 |
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Intention to Treat Analysis; Lithium; Male; Medical Futility; Middle Aged; Patient Selection; Prognosis; Riluzole; Treatment Outcome | 2010 |
Other Studies
2 other study(ies) available for riluzole and lithium
| Article | Year |
|---|---|
Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord.
Topics: Animals; Apoptosis; Autophagy; Calcium; Cell Death; Chick Embryo; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Agonists; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; In Vitro Techniques; Kainic Acid; Lithium; Motor Neurons; Neuroprotective Agents; Riluzole; Signal Transduction; Spinal Cord | 2010 |
The neuroprotection exerted by memantine, minocycline and lithium, against neurotoxicity of CSF from patients with amyotrophic lateral sclerosis, is antagonized by riluzole.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Survival; Excitatory Amino Acid Antagonists; Humans; Lithium; Memantine; Minocycline; Neurons; Neuroprotective Agents; Rats; Riluzole | 2014 |